Skip to content
tedizolid
EntityQ7825683· pop 17· linked from 448 articles

Also known as Torezolid, DA 7157, DA-7157, TR-700, TR 700

Tedizolid, sold under the brand name Sivextro (by Merck) is an oxazolidinone-class antibiotic. Tedizolid phosphate is a phosphate ester prodrug of the active compound tedizolid. It was developed by Cubist Pharmaceuticals, following acquisition of Trius Therapeutics (originator: Dong-A Pharmaceuticals), and is marketed for the treatment of acute bacterial skin and skin structure infections (also known as complicated skin and skin-structure infections (cSSSIs)).

Key facts

Drug.F
1
Drug.N
6
Drug.O
3
Drug.Verifiedfields
changed
Drug.verifiedrevid
470611892
Drug.image
Tedizolid.svg
Drug.image_class
skin-invert-image
Drug.image2
Tedizolid 3D molecule.png
Drug.image_class2
bg-transparent
Drug.tradename
Sivextro
Drug.MedlinePlus
a614038
Drug.DailyMedID
Tedizolid
Drug.routes_of_administration
By mouth, intravenous
Drug.ATC_prefix
J01
Drug.ATC_suffix
XX11
Drug.legal_CA
Rx-only
Drug.legal_US
Rx-only
Drug.legal_EU
Rx-only

via Wikipedia infobox

Research

545 papers

via PubMed

~7 min read

Encyclopedic overview

7 sections
Contents
  • Medical uses
  • Mechanism of action
  • Pharmacokinetic/pharmacodynamic (PK/PD) properties
  • Clinical trials
  • Adverse effects
  • References
  • External links

{{Infobox drug | Verifiedfields = changed | verifiedrevid = 470611892 | image = Tedizolid.svg | image_class = skin-invert-image | alt = | image2 = Tedizolid 3D molecule.png | image_class2 = bg-transparent | alt2 =

| pronounce = | tradename = Sivextro | Drugs.com = | MedlinePlus = a614038 | DailyMedID = Tedizolid | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth, intravenous | ATC_prefix = J01 | ATC_suffix = XX11

Excerpted from Wikipedia’s “tedizolid” article, available under the CC BY-SA 4.0 licence.

Gallery (2)